PeopleBio, Inc. (KOSDAQ:304840)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,091.00
-67.00 (-5.79%)
At close: May 20, 2026
Market Cap26.47B -56.2%
Revenue (ttm)2.85B +12.6%
Net Income-15.71B
EPS-722.13
Shares Out24.26M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume73,800
Average Volume213,400
Open1,158.00
Previous Close1,158.00
Day's Range1,070.00 - 1,160.00
52-Week Range600.00 - 2,970.00
Betan/a
RSI40.79
Earnings DateApr 3, 2026

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam-si, South Korea. [Read more]

Founded 2002
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 304840
Full Company Profile

Financial Performance

In 2025, PeopleBio's revenue was 2.85 billion, an increase of 12.64% compared to the previous year's 2.53 billion. Losses were -15.71 billion, 44.0% more than in 2024.

Financial Statements